The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis

被引:133
作者
Hallstrand, TS
Boitano, LJ
Johnson, WC
Spada, CA
Hayes, JG
Raghu, G
机构
[1] Univ Washington, Dept Med, Div Pulm & Crit Care Med, Seattle, WA 98195 USA
[2] Univ Washington, Med Ctr, Chest Clin Interstitial Lung Dis, Sarcoid & Pulm Fibrosis Program,Dept Biostat, Seattle, WA 98195 USA
关键词
idiopathic pulmonary fibrosis; interstitial lung disease; pulmonary function; survival walk test;
D O I
10.1183/09031936.04.00137203
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Idiopathic pulmonary fibrosis (IPF) is a relentlessly progressive disease with a median survival of similar to3 yrs. Measurements of airflow and lung volumes at rest are generally used to monitor the clinical course in this disorder. This study was designed to determine if a modified version of the 6-min walk test, called the timed walk test, accurately characterises disease severity and survival in IPF. The study population consisted of 28 patients with well-characterised progressive IPF. The timed walk test and concurrent measures of disease severity were assessed at baseline. Participants were prospectively followed for greater than or equal to4 yrs to determine the relationship between parameters of the timed walk test and survival. There were strong correlations between the end-exercise saturation and walk-velocity parameters of the timed walk test and diffusing capacity, and arterial oxygen tension at rest. In univariate Cox proportional-hazards models, end-exercise saturation, change in saturation with exercise, walk distance and walk velocity were associated with survival. In unadjusted logistic regression models, odds of death at 2 yrs were associated with the same parameters. In conclusion, the timed walk test relates to disease severity and long-term outcome in progressive idiopathic pulmonary fibrosis.
引用
收藏
页码:96 / 103
页数:8
相关论文
共 36 条
[1]  
*AM THOR SOC EUR R, 2001, AM THOR SOC EUR RESP
[2]  
[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107
[3]  
[Anonymous], 2000, AM J RESP CRIT CARE, V161, P646, DOI DOI 10.1164/AJRCCM.161.2.ATS3-00
[4]   PREDICTION OF MORTALITY AND MORBIDITY WITH A 6-MINUTE WALK TEST IN PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION [J].
BITTNER, V ;
WEINER, DH ;
YUSUF, S ;
ROGERS, WJ ;
MCINTYRE, KM ;
BANGDIWALA, SI ;
KRONENBERG, MW ;
KOSTIS, JB ;
KOHN, RM ;
GUILLOTTE, M ;
GREENBERG, B ;
WOODS, PA ;
BOURASSA, MG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (14) :1702-1707
[5]  
Brooks Dina, 2002, Can Respir J, V9, P99
[6]  
CARRINGTON CB, 1978, NEW ENGL J MED, V298, P801, DOI 10.1056/NEJM197804132981501
[7]  
Chetta A, 2001, SARCOIDOSIS VASC DIF, V18, P170
[8]   Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis [J].
Collard, HR ;
King, TE ;
Bartelson, BB ;
Vourlekis, JS ;
Schwarz, MI ;
Brown, KK .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 168 (05) :538-542
[9]   Arterial blood gas reference values for sea level and an altitude of 1,400 meters [J].
Crapo, RO ;
Jensen, RL ;
Hegewald, M ;
Tashkin, DP .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (05) :1525-1531
[10]   Reliability, validity, and responsiveness of the six-minute walk test in patients with heart failure [J].
Demers, C ;
McKelvie, RS ;
Negassa, A ;
Yusuf, S .
AMERICAN HEART JOURNAL, 2001, 142 (04) :698-703